Table 2. Total Cellular Protein Levels of NR2B and GluR1 Were Differentially Expressed in MPFC and Hippocampus, 24 h Following Treatment with Either GLYX-13 (3 mg/kg, IV) or Ketamine (10 mg/kg, IV), as Measured by Western Blot. Data are Expressed as Mean±SEM % of Control Levels.

	NR2B	GluR1
MPFC 24 h
Vehicle	100±26	100±10
GLYX-13	242±38*	104±17
Ketamine	196±28*	95±15
Hippocampus 24 h
Vehicle	100±21	100±7
GLYX-13	129±19	116±8
Ketamine	89±13	116±2

n=4–11 per group.

*P<0.05, Fisher's PLSD post hoc test vs vehicle.